VTRS ▲ +2.4% - Viatris Inc.
$VTRS VTRS - Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
16-OCT-2026 04:05 PM ET
Share this post
More filings for $VTRS
VTRS ▼ -1.9% - Viatris Inc.Oct 8, 2026VTRS ▼ -1.9% - Viatris Inc.Oct 8, 2026VTRS ▲ +0.3% - Viatris Inc.Oct 5, 2026VTRS - Viatris Inc. - SEC Filing Update (08-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 8, 2026VTRS - Viatris Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026
View full $VTRS filing history →💬 Comments
Loading comments…
Leave a comment